An open label, double arm, multicenter, randomized, controlled, clinical study to evaluate the efficacy and safety of an anti-viral polyherbal phytochemical composition Virowin (Mfd. By Amulya Herbs, Haryana) in conjunction with multivitamin Energy Z capsules (Mkt. By Amulya Herbs, Haryana) compared with standard protocol in treating mild to moderate COVID-19 patients.

Amulya Herbs0 个研究点目标入组 60 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Gender: Either male or non-pregnant, non-lactating female aged > 18-70 < years (both inclusive).
•2. Patients with RT-PCR confirmed diagnosis of COVID-19
•3. Patients with mild to moderate COVID-19 infection
•4. Subjects willing to give written informed consent
•5. Subjects able to take the Product orally and comply with the study protocol
•6. Women of child bearing potential must have a negative urine pregnancy test prior to study entry

•1.Patients with persistent vomiting
•2.Critically ill patients
•3.Patients with known active hepatitis, tuberculosis and definite bacterial or fungal infections
•4.Patients with altered mental state
•5.Patients with multiple organ failure requiring ICU monitoring and treatment
•6.Patients with respiratory failure and requiring mechanical ventilation
•7.Patients with shock
•8.Patients with any concurrent medical condition or uncontrolled, clinically significant systemic disease (e.g. heart failure, hypertension, liver disease, diabetes, anemia etc.) that, in the opinion of investigator precludes the subjectâ??s participation in the study or interferes with the interpretation of the study results.
•9.Patients with history of serology tests positive for hepatitis B, hepatitis C, or human immunodeficiency virus.
•10.Patients who have received specific antiviral drugs ritonavir/lopinavir, or chloroquine, hydroxychloroquine, azithromycin, monoclonal antibodies within 1 week before admission
•11.Patient who have participated in another investigational study within 3 months prior to enrolment in this study
•12.Investigators, study personnel, sponsorâ??s representatives and their first-degree relatives.
•13.Pregnant subjects

发起方

Amulya Herbs